CircNet

General Information

circRNA Basic Information

CircID	chr5:10415488\|10426522
Strand	+
CircType	exon
Host Gene	ENSG00000145495.14;
Algorism	find_circ;CIRI2;DCC;
Sequence	TATTTGCTGGCCGTTGGTTAATGTCGTTTTGGACGGGGACTGCCAAAATCCATGAGCTCTACACAGCTGCTTGTGGTCTCTATGTTTGCTGGCTAACCATAAGGGCTGTGACGGTGATGGTGGCATGGATGCCTCAGGGACGCAGAGTGATCTTCCAGAAGGTTAAAGAGTGGTCTCTCATGATCATGAAGACTTTGATAGTTGCGGTGCTGTTGGCTGGAGTTGTCCCTCTCCTTCTGGGGCTCCTGTTTGAGCTGGTCATTGTGGCTCCCCTGAGGGTTCCCTTGGATCAGACTCCTCTTTTTTATCCATGGCAGGACTGGGCACTTGGAGTCCTGCATGCCAAAATCATTGCAGCTATAACATTGATGGGTCCTCAGTGGTGGTTGAAAACTGTAATTGAACAGGTTTACGCAAATGGCATCCGGAACATTGACCTTCACTATATTGTTCGTAAACTGGCAGCTCCCGTGATCTCTGTGCTGTTGCTTTCCCTGTGTGTACCTTATGTCATAGCTTCTGGTGTTGTTCCTTTACTAG

circRNA Expression in different cancers

circRNA-miRNA-gene regulatory network

Target miRNAs

CircID	miRNA	PITA	miRanda	targetScan
chr5:10415488\|10426522	hsa-miR-22-3p	0	1	1

Target Genes

Note about Function Analysis:
We also provide this interface that can help researchers to perform GO, KEGG and disease enrichment analysis easily. This function will take around 30 seconds. After the analysis, this page will automatically jump to the result page.

Target miRNA Expression in different cancers

circRNA Open Reading Frame (ORF)

RNA Binding Protein (RBP) of circRNA

CircID	RBP	Number of Upstream Sites	Number of Downstream Sites	Number of Circ Exons Sites
chr5:10415488\|10426522	RBM5	0	0	1
chr5:10415488\|10426522	NOP56	1	0	2
chr5:10415488\|10426522	MOV10	4	0	4
chr5:10415488\|10426522	ELAVL1	6	4	7
chr5:10415488\|10426522	SF3B4	2	0	0
chr5:10415488\|10426522	SF3B1	0	2	0
chr5:10415488\|10426522	CELF2	3	3	4
chr5:10415488\|10426522	CNBP	0	0	3
chr5:10415488\|10426522	YTHDF1	2	0	0
chr5:10415488\|10426522	SLBP	0	1	0
chr5:10415488\|10426522	FMR1	5	0	11
chr5:10415488\|10426522	TAF15	1	1	1
chr5:10415488\|10426522	CAPRIN1	2	0	0
chr5:10415488\|10426522	CPSF7	3	0	1
chr5:10415488\|10426522	CPSF6	2	0	0
chr5:10415488\|10426522	NUDT21	5	1	0
chr5:10415488\|10426522	RBM15B	1	0	0
chr5:10415488\|10426522	TROVE2	1	0	0
chr5:10415488\|10426522	FUS	2	0	1
chr5:10415488\|10426522	DGCR8	0	0	2
chr5:10415488\|10426522	QKI	1	0	0
chr5:10415488\|10426522	SRSF1	1	1	3
chr5:10415488\|10426522	NOP58	1	4	6
chr5:10415488\|10426522	SRSF3	0	3	0
chr5:10415488\|10426522	U2AF1	0	0	2
chr5:10415488\|10426522	U2AF2	12	6	7
chr5:10415488\|10426522	SRSF9	0	0	1
chr5:10415488\|10426522	HNRNPU	2	0	0
chr5:10415488\|10426522	DDX54	3	0	14
chr5:10415488\|10426522	EIF3G	1	0	0
chr5:10415488\|10426522	EFTUD2	0	0	2
chr5:10415488\|10426522	RBM10	3	2	0
chr5:10415488\|10426522	CPSF1	1	0	0
chr5:10415488\|10426522	RBM15	1	0	0
chr5:10415488\|10426522	AUH	0	0	2
chr5:10415488\|10426522	FIP1L1	1	0	1
chr5:10415488\|10426522	PTBP1	8	18	3
chr5:10415488\|10426522	HNRNPC	32	1	0
chr5:10415488\|10426522	HNRNPA1	8	2	0
chr5:10415488\|10426522	DDX3X	15	0	0
chr5:10415488\|10426522	ZC3H7B	2	0	2
chr5:10415488\|10426522	LARP4B	1	0	0
chr5:10415488\|10426522	SMNDC1	0	0	1
chr5:10415488\|10426522	MSI2	0	0	2
chr5:10415488\|10426522	ACIN1	0	0	8
chr5:10415488\|10426522	LIN28B	8	2	9
chr5:10415488\|10426522	LIN28A	1	0	1
chr5:10415488\|10426522	FXR1	0	0	2
chr5:10415488\|10426522	FXR2	3	0	6
chr5:10415488\|10426522	SND1	1	0	11
chr5:10415488\|10426522	IGF2BP1	2	0	15
chr5:10415488\|10426522	IGF2BP3	4	0	12
chr5:10415488\|10426522	IGF2BP2	5	0	17
chr5:10415488\|10426522	TARDBP	4	0	0
chr5:10415488\|10426522	YTHDC1	2	0	0
chr5:10415488\|10426522	FBL	1	1	4
chr5:10415488\|10426522	KHSRP	1	0	0
chr5:10415488\|10426522	PRPF8	1	1	2
chr5:10415488\|10426522	AGO1	1	0	0
chr5:10415488\|10426522	DDX24	2	0	1
chr5:10415488\|10426522	CSTF2T	1	1	3
chr5:10415488\|10426522	SRRM4	1	0	0
chr5:10415488\|10426522	CSTF2	0	1	0
chr5:10415488\|10426522	SF3A3	1	0	0
chr5:10415488\|10426522	RBM22	0	2	4
chr5:10415488\|10426522	HNRNPK	0	2	0
chr5:10415488\|10426522	WDR33	1	0	0
chr5:10415488\|10426522	PPIG	1	0	0
chr5:10415488\|10426522	UPF1	8	1	0
chr5:10415488\|10426522	AIFM1	0	0	1
chr5:10415488\|10426522	ATXN2	1	0	1
chr5:10415488\|10426522	RBM47	1	0	0
chr5:10415488\|10426522	EIF4A3	9	4	8
chr5:10415488\|10426522	AGO2	5	1	15

CircRNA Information